Replies to post #3413 on Mind Medicine (MindMed) Inc (MNMD)

[Bruinfan4ever]

Wolf Says;

The 20 plus million acquisition and 24 new employees will definitely affect the bottom line including the new medical chiefs salary. How much salary for these people is it going to add up to?

It doesn't matter what it adds up to if the digital side is ready when the drugs make it to approval. Do you expect them to get approved drugs and then start working on the digital medicine side?

[Thinman13]

For the moment, set aside the LSD trials and focus on 18-MC. This is where the BIG money is. My degree is in botany and chemistry of plants and 30 years ago I studied Schultes work on Tabernanthe ibogo, the plant from which ibogaine is extracted. Even back then it was noted how users of the crude extract of Iboga experienced a very high degree of addiction cure. Unfortunately, the Iboga experience is a grueling 36 hour long trip. So what MindMed chemists have accomplished with 18-MC is a non-hallucinogenic version of the ibogaine alkaloid that still retain the anti-addiction property. This huge beyond huge. This one drug could be valued at multiples of $10 billion dollars. 18-MC is touted as the "antibiotic for addiction". Let that sink in. Now Kevin O'Leary let it sink in and out of all the osych companies out there, he chose MindMed. He has a history of choosing wisely and of not losing his money.
If you have the time, find a copy of The Botany and Chemistry of Hallucinogenic Plants by Dr Richard Evans Scvhultes and read the chapter on Ibogaine.